Free Trial

Verona Pharma PLC American Depositary Share (VRNA) Competitors

Verona Pharma PLC American Depositary Share logo
$104.90 +0.12 (+0.11%)
Closing price 04:00 PM Eastern
Extended Trading
$104.86 -0.05 (-0.04%)
As of 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VRNA vs. ARGX, ONC, BNTX, INSM, SMMT, TEVA, ITCI, GMAB, MRNA, and RDY

Should you be buying Verona Pharma PLC American Depositary Share stock or one of its competitors? The main competitors of Verona Pharma PLC American Depositary Share include argenex (ARGX), BeOne Medicines (ONC), BioNTech (BNTX), Insmed (INSM), Summit Therapeutics (SMMT), Teva Pharmaceutical Industries (TEVA), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Moderna (MRNA), and Dr. Reddy's Laboratories (RDY). These companies are all part of the "pharmaceutical products" industry.

Verona Pharma PLC American Depositary Share vs. Its Competitors

argenex (NASDAQ:ARGX) and Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability.

60.3% of argenex shares are held by institutional investors. Comparatively, 85.9% of Verona Pharma PLC American Depositary Share shares are held by institutional investors. 2.4% of argenex shares are held by company insiders. Comparatively, 4.8% of Verona Pharma PLC American Depositary Share shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

argenex has a net margin of 40.20% compared to Verona Pharma PLC American Depositary Share's net margin of 0.00%. argenex's return on equity of 16.15% beat Verona Pharma PLC American Depositary Share's return on equity.

Company Net Margins Return on Equity Return on Assets
argenex40.20% 16.15% 14.33%
Verona Pharma PLC American Depositary Share N/A -69.65%-28.00%

argenex has higher revenue and earnings than Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share is trading at a lower price-to-earnings ratio than argenex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
argenex$2.25B15.34$833.04M$16.2134.83
Verona Pharma PLC American Depositary Share$42.28M211.21-$173.42M-$2.00-52.45

In the previous week, Verona Pharma PLC American Depositary Share had 10 more articles in the media than argenex. MarketBeat recorded 25 mentions for Verona Pharma PLC American Depositary Share and 15 mentions for argenex. argenex's average media sentiment score of 1.16 beat Verona Pharma PLC American Depositary Share's score of 0.44 indicating that argenex is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
argenex
7 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Verona Pharma PLC American Depositary Share
12 Very Positive mention(s)
6 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

argenex has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500. Comparatively, Verona Pharma PLC American Depositary Share has a beta of 0.24, suggesting that its stock price is 76% less volatile than the S&P 500.

argenex presently has a consensus price target of $728.06, suggesting a potential upside of 28.95%. Verona Pharma PLC American Depositary Share has a consensus price target of $109.00, suggesting a potential upside of 3.91%. Given argenex's stronger consensus rating and higher possible upside, equities analysts plainly believe argenex is more favorable than Verona Pharma PLC American Depositary Share.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
argenex
0 Sell rating(s)
0 Hold rating(s)
19 Buy rating(s)
2 Strong Buy rating(s)
3.10
Verona Pharma PLC American Depositary Share
0 Sell rating(s)
11 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.15

Summary

argenex beats Verona Pharma PLC American Depositary Share on 13 of the 17 factors compared between the two stocks.

Get Verona Pharma PLC American Depositary Share News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VRNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VRNA vs. The Competition

MetricVerona Pharma PLC American Depositary ShareMED IndustryMedical SectorNASDAQ Exchange
Market Cap$8.92B$2.96B$5.54B$9.41B
Dividend YieldN/A2.47%3.75%4.03%
P/E Ratio-52.4519.7528.0119.82
Price / Sales211.21299.50432.7298.44
Price / CashN/A42.5936.1658.27
Price / Book40.987.678.125.65
Net Income-$173.42M-$55.28M$3.25B$257.91M
7 Day Performance0.07%2.50%0.97%2.09%
1 Month Performance15.38%11.70%7.36%11.13%
1 Year Performance364.57%4.89%31.31%18.40%

Verona Pharma PLC American Depositary Share Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRNA
Verona Pharma PLC American Depositary Share
2.2988 of 5 stars
$104.90
+0.1%
$109.00
+3.9%
+358.8%$8.92B$42.28M-52.4530
ARGX
argenex
4.4954 of 5 stars
$561.28
+0.2%
$728.06
+29.7%
+23.6%$34.35B$2.25B34.631,599Positive News
Analyst Revision
ONC
BeOne Medicines
2.5583 of 5 stars
$252.14
+0.7%
$320.67
+27.2%
N/A$27.63B$3.81B-67.7811,000Analyst Forecast
Gap Up
BNTX
BioNTech
1.4591 of 5 stars
$111.00
-1.7%
$137.91
+24.2%
+28.4%$26.68B$2.98B-32.656,772Analyst Forecast
INSM
Insmed
3.8659 of 5 stars
$101.89
+3.8%
$108.07
+6.1%
+37.9%$19.33B$381.03M-17.121,271Positive News
Analyst Forecast
Insider Trade
SMMT
Summit Therapeutics
2.886 of 5 stars
$25.40
+1.6%
$34.67
+36.5%
+196.8%$18.86BN/A-74.70110
TEVA
Teva Pharmaceutical Industries
4.1195 of 5 stars
$16.43
+0.2%
$24.71
+50.5%
-0.4%$18.84B$16.54B-14.2836,830
ITCI
Intra-Cellular Therapies
0.9187 of 5 stars
$131.87
flat
$109.70
-16.8%
N/A$14.05B$680.50M-151.57560
GMAB
Genmab A/S
3.9168 of 5 stars
$21.46
+0.3%
$37.80
+76.1%
-18.0%$13.77B$3.12B12.192,682Positive News
Analyst Revision
MRNA
Moderna
4.2835 of 5 stars
$32.88
-2.3%
$46.61
+41.8%
-74.0%$12.72B$3.24B-3.775,800Trending News
Options Volume
Analyst Revision
RDY
Dr. Reddy's Laboratories
2.3577 of 5 stars
$14.58
+0.4%
$16.95
+16.3%
-6.6%$12.17B$325.54B22.0827,811News Coverage
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:VRNA) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners